These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1641484)

  • 41. [Assessment of myocardial vitality with FDG-PET: still research or ready for general practice?].
    Schröter G; Schwaiger M
    Herz; 1995 Oct; 20(5):350-3. PubMed ID: 7498882
    [No Abstract]   [Full Text] [Related]  

  • 42. Myocardial blood flow, deoxyglucose uptake, and myocyte viability in ischemia.
    Opie LH; Camici PG
    J Nucl Med; 1992 Jul; 33(7):1353-6. PubMed ID: 1613577
    [No Abstract]   [Full Text] [Related]  

  • 43. Noninvasive detection of functionally significant coronary artery stenoses with exercise and positron emission tomography.
    Krivokapich J; Huang SC; Ratib O; Schelbert HR
    Am Heart J; 1991 Jul; 122(1 Pt 1):202-11. PubMed ID: 2063738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose.
    Tamaki N; Ohtani H; Yamashita K; Magata Y; Yonekura Y; Nohara R; Kambara H; Kawai C; Hirata K; Ban T
    J Nucl Med; 1991 Apr; 32(4):673-8. PubMed ID: 2013806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function.
    Beanlands RS; deKemp RA; Smith S; Johansen H; Ruddy TD
    Am J Cardiol; 1997 Apr; 79(8):1092-5. PubMed ID: 9114769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitation of the regional blood flow in the interventricular septum using positron emission tomography and nitrogen-13 ammonia.
    Hove JD; Gambhir SS; Kofoed KF; Freiberg J; Kelbaek H
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):109-16. PubMed ID: 12483417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitrogen-13 ammonia perfusion imaging: relation to metabolic imaging.
    Niemeyer MG; Kuijper AF; Gerhards LJ; D'Haene EG; van der Wall EE
    Am Heart J; 1993 Mar; 125(3):848-54. PubMed ID: 8438714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative measurement of regional myocardial blood flow in patients with coronary artery disease by intravenous injection of 13N-ammonia in positron emission tomography.
    Hara T; Michihata T; Yokoi F; Sakamoto S; Masuoka T; Iio M
    Eur J Nucl Med; 1990; 16(4-6):231-5. PubMed ID: 2351171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nitrogen-13 ammonia positron emission tomography--myocardial perfusion imaging].
    Himi T; Masuda Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):641-5. PubMed ID: 12436595
    [No Abstract]   [Full Text] [Related]  

  • 50. Application of positron emission tomography in the heart. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel.
    JAMA; 1988 Apr 22-29; 259(16):2438-45. PubMed ID: 3280846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interpolating scan and oblique-angle tomograms in myocardial PET using nitrogen-13 ammonia.
    Senda M; Yonekura Y; Tamaki N; Saji H; Koide H; Nohara R; Kambara H; Konishi Y; Torizuka K
    J Nucl Med; 1986 Dec; 27(12):1830-6. PubMed ID: 3491190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical usefulness of positron computed tomographic imaging with 18FDG, 13NH3 and 11CO in cerebrovascular diseases].
    Shishido F; Tateno Y; Takashima T; Yamaura A; Ikehira H; Yamasaki T; Irie T; Fukushi K; Inoue O; Tamate K; Suzuki K; Nakayama T; Iinuma T; Tanaka E; Kurisu A
    Kaku Igaku; 1982 Aug; 19(7):987-1000. PubMed ID: 6983614
    [No Abstract]   [Full Text] [Related]  

  • 53. Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy.
    J Nucl Med; 1991 Jan; 32(1):130-5. PubMed ID: 1988617
    [No Abstract]   [Full Text] [Related]  

  • 54. Nitrogen-13 ammonia cardiac positron emission tomography in mice: effects of clonidine-induced changes in cardiac work on myocardial perfusion.
    Inubushi M; Jordan MC; Roos KP; Ross RS; Chatziioannou AF; Stout DB; Dahlbom M; Schelbert HR
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):110-6. PubMed ID: 14551749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What is the best approach to quantify myocardial blood flow with pet?
    Hutchins GD
    J Nucl Med; 2001 Aug; 42(8):1183-4. PubMed ID: 11483677
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cardiac positron emission tomography--current status and future perspectives].
    Armbrecht JJ; Schelbert HR
    Z Kardiol; 1990 Mar; 79(3):151-60. PubMed ID: 2191506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noninvasive evaluation of regional myocardial perfusion with positron emission computed tomography.
    Torizuka K; Yonekura Y; Tamaki N; Senda M; Saji H
    Jpn Circ J; 1985 Jul; 49(7):719-26. PubMed ID: 3877184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Whole heart distribution of myocardial perfusion, metabolism and myocardial viability by positron emission tomography.
    Araujo LI; Maseri A
    Br Med Bull; 1989 Oct; 45(4):922-32. PubMed ID: 2695219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical indications for PET of the heart].
    von Schulthess GK; Schwaiger M
    Schweiz Rundsch Med Prax; 1993 Aug; 82(34):914-8. PubMed ID: 8372296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noninvasive detection of heart transplant rejection with positron emission scintigraphy.
    Hoff SJ; Stewart JR; Frist WH; Kessler RM; Sandler MP; Atkinson JB; Votaw J; Carey JA; Ansari MS; Merrill WH
    Ann Thorac Surg; 1992 Apr; 53(4):572-7. PubMed ID: 1554263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.